Ontario Drug Benefit Program: A Change in Policy

The generic pharmaceutical industry in Canada began its meteoric growth when the Trudeau liberals passed a law allowing small Canadian companies to sell patented pharmaceuticals under a “compulsory licensing” arrangement. The law was in force long enough to build a truly effective generic industry but was repealed when the Mulroney conservatives came into power, supposedly Continue Reading